Product Images Azacitidine

This is a pharmaceutical product. It is a lyophilized toxic substance, available in a single vial of 100 mg/vial, to be diluted for subcutaneous and intravenous use only. The manufacturer is Dr. Reddy's. The text also includes some dosage instructions and disposal guidelines. However, the text seems to be incomplete and contains errors.*

This is a description of Azacitidine injections used for subcutaneous and intravenous use. The injections come in a lyophilized form and must be diluted before use. Each vial contains 100mg of Azacitidine. The text also provides instructions for the storage of the injections.*

Description: This is a medication that comes in a single-dose vial with 100 mg powder for subcutaneous and intravenous use. The medication is a cytotoxic agent that needs to be diluted before use. The text also includes some brand or manufacturer's name and some unreadable characters, which are not relevant to describe the medication.*

This is a survival analysis between two groups (AZA and CCR) and the log-rank test shows a statistically significant difference (p=0.0001) in their survival rates over time. The hazard ratio for AZA compared to CCR is 0.58 (95% CI: 0.43-0.77) meaning AZA has lower risk of death. The number of deaths for AZA and CCR are 82 and 113 respectively. The graph shows the proportion of patients surviving over time (in months) for both groups.*